Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guben Qushi Decoction
- Development stage
- Phase 1
- Lead developer
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
- Administration
- Oral
01
Overview
Guben Qushi Decoction is a traditional Chinese medicine (TCM) formula developed by The Second Affiliated Hospital of Guangzhou University of Chinese Medicine for the treatment of eczema. Specifically formulated for the 'spleen-deficiency dampness-type' TCM syndrome, the decoction aims to strengthen the spleen and eliminate dampness, which are believed to be underlying causes of chronic skin inflammation in this patient population. It is currently being evaluated in clinical trials to assess its safety, clinical efficacy, and preliminary mechanisms of action in adults with eczema.
- Other names
- Guben Qushi PrescriptionGubenhuashi Decoction
Beyond the preview
Go deeper on Guben Qushi Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guben Qushi Decoction.